Cover Story
Free
By Paul Goldberg and Matthew Bin Han Ong
FDA may have escaped the devastating cuts in President Trump's first budget proposal, while NIH ended up taking the brunt of its fury.
In Brief
Drugs & Targets
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- My bad: I left out Fox Chase
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials
- NCI creates Cancer Equity Leaders group to improve cancer health equity
- Edward Copeland, surgeon and breast cancer expert, dies at 86